COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

COST

978.18

+0.73%↑

PG

159.85

+0.47%↑

PM

186.26

+1.94%↑

PEP

169.19

+1.34%↑

MO

65.92

+2.38%↑

Search

USANA Health Sciences Inc

Закрыт

21.06 -1.63

Обзор

Изменение цены акций

24 ч

Текущая

Мин.

20.62

Макс.

21.43

Ключевые показатели

By Trading Economics

Доход

-17M

-6.7M

Продажи

-22M

214M

P/E

Средняя по отрасли

23.556

33.023

Прибыль на акцию

-0.15

Рентабельность продаж

-3.118

Сотрудники

1,700

EBITDA

-17M

11M

Дивиденды

By Dow Jones

Следующий отчет о доходах

17 февр. 2026 г.

Рыночная статистика

By TradingEconomics

Рыночная капитализация

5.9M

388M

Предыдущая цена открытия

22.69

Предыдущая цена закрытия

21.06

Техническая оценка

By Trading Central

Уверенность

Weak Bullish Evidence

USANA Health Sciences Inc График

Прошлые результаты не являются надежным индикатором будущих результатов.

Связанные новости

10 февр. 2026 г., 23:26 UTC

Главные движущие силы рынка

Moderna Stock Slips After FDA Refuses Flu Vaccine Review

10 февр. 2026 г., 22:31 UTC

Отчет

Correction to America Movil 4Q Profit Article

10 февр. 2026 г., 22:22 UTC

Отчет

America Movil 4Q Profit Jumps on Lower Financial Costs

10 февр. 2026 г., 23:51 UTC

Обсуждения рынка
Отчет

Commonwealth Bank's Margin Management Gives It a Platform -- Market Talk

10 февр. 2026 г., 23:42 UTC

Обсуждения рынка

Gold Rises Amid Fed Rate-Cut Prospects -- Market Talk

10 февр. 2026 г., 23:40 UTC

Обсуждения рынка
Отчет

Commonwealth Bank Bear Says 1H Result Looks Strong -- Market Talk

10 февр. 2026 г., 23:21 UTC

Обсуждения рынка

Ford Says EV Shift Was Driven by Demand Changes -- Market Talk

10 февр. 2026 г., 23:21 UTC

Обсуждения рынка

Global Equities Roundup: Market Talk

10 февр. 2026 г., 22:17 UTC

Обсуждения рынка

Australia's One Nation Now Commands Working Class Vote -- Market Talk

10 февр. 2026 г., 22:15 UTC

Отчет

Humana Earnings Will Shed More Light on Medicare Prospects -- Barrons.com

10 февр. 2026 г., 22:10 UTC

Отчет

Intact Financial 4Q Book Value Per Share Was C$107.35 >IFC.T

10 февр. 2026 г., 22:10 UTC

Отчет

Intact Financial Raises Qtr Dividend to C$1.47 >IFC.T

10 февр. 2026 г., 22:09 UTC

Отчет

Intact Financial 4Q Combined Ratio Was 85.9% >IFC.T

10 февр. 2026 г., 22:09 UTC

Отчет

Intact Financial 4Q Adj EPS C$5.50 >IFC.T

10 февр. 2026 г., 22:01 UTC

Отчет

Intact Financial 4Q EPS C$5.24 >IFC.T

10 февр. 2026 г., 21:54 UTC

Отчет

James Hardie Industries Sees FY26 Total Adjusted EBITDA $1.232B to $1.263B >JHX

10 февр. 2026 г., 21:53 UTC

Отчет

Robinhood Stock Tumbles as Crypto-Related Revenue Falls Short of Expectations -- Barrons.com

10 февр. 2026 г., 21:51 UTC

Отчет

James Hardie Industries Sees FY26 Free Cash Flow at Least $200M

10 февр. 2026 г., 21:51 UTC

Отчет

Gilead Earnings Surprise. Why The Stock Is Tumbling Anyway. -- Barrons.com

10 февр. 2026 г., 21:51 UTC

Отчет

James Hardie Industries: Focused on the Achievement of $125 M Target >JHX

10 февр. 2026 г., 21:51 UTC

Отчет

James Hardie Industries: Integration and Cost Synergies Ahead of Schedule >JHX

10 февр. 2026 г., 21:51 UTC

Отчет
Приобретения, слияния, поглощения

Evolution Net Debt A$362 Million at Dec. 31 Vs A$1.29 Billion Year Earlier

10 февр. 2026 г., 21:50 UTC

Отчет
Приобретения, слияния, поглощения

Evolution: Gearing 6% at Dec. 31, From 23% a Year Earlier

10 февр. 2026 г., 21:50 UTC

Отчет

James Hardie Industries 3Q EPS 12c >JHX

10 февр. 2026 г., 21:50 UTC

Обсуждения рынка

Basic Materials Roundup: Market Talk

10 февр. 2026 г., 21:50 UTC

Отчет

James Hardie Industries 3Q Adj EPS 24c >JHX

10 февр. 2026 г., 21:49 UTC

Отчет

James Hardie Industries 3Q Sales $1.24B >JHX

10 февр. 2026 г., 21:49 UTC

Отчет
Приобретения, слияния, поглощения

Evolution 1H Operating Mine Cash Flow a Record A$1.73 Billion

10 февр. 2026 г., 21:48 UTC

Отчет
Приобретения, слияния, поглощения

Evolution 1H Ebitda A$1.56 Billion, Up 59% On-Year

10 февр. 2026 г., 21:47 UTC

Отчет
Приобретения, слияния, поглощения

Evolution 1H Revenue A$2.79 Billion, Up 37% On-Year

Сравнение c конкурентами

Изменение цены

USANA Health Sciences Inc Прогноз

Консенсус по рейтингу

By TipRanks

0 ratings

0

Покупка

0

Удержание

0

Продажа

Техническая оценка

By Trading Central

28.405 / 29.84Поддержка и Сопротивление

Краткосрочная

Weak Bullish Evidence

Среднесрочная

Bullish Evidence

Долгосрочная

No Evidence

Финансовые показатели

Расходы на продажи и администрирование

Операционные расходы

Прибыль до уплаты налогов

Продажи

Себестоимость реализации

Валовая прибыль от продаж

Процентные расходы по долгу

EBITDA

Операционная прибыль

$

О компании USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
help-icon Live chat